Skip to product information
PNC-28 (20mg)
  • PNC-28 (20mg)
  • PNC-28 (20mg)
PNC-28 (20mg)

PNC-28 (20mg)

$200.00

PNC-28 (20mg)

This research vial contains PNC-28, a synthetic peptide studied for its potential anti-tumor properties through targeted disruption of MDM2–p53 interactions. Researchers have explored PNC-28 for its effects on inducing apoptosis in cancer cells and enhancing p53 activity in preclinical cancer models.

Blend Composition (Per Vial):
PNC-28 – 20mg

Key Characteristics:

  • PNC-28: Synthetic peptide studied for tumor suppression via p53 activation

  • Investigated for apoptosis induction and selective cancer cell cytotoxicity

  • Sterile vial format supports stability and controlled reconstitution

  • Stable composition optimized for reproducibility in oncology-related research

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.

You may also like